Anticoagulation in prosthetic valve endocarditis

John L. Carpenter, C. Kenneth McAllister, John Boslego, Joel Brown, John L. Carpenter, Ray Chung, Ronald Cooper, D. Baxter Craig, Alan Cross, David Haburchak, Shannon Harrison, Charles Hoke, Bruce McClain, Debra Omori, Steven Opal, Robert Redfield, Gerald Sadoff, Edmund Tramont

Research output: Contribution to journalArticle

42 Scopus citations

Abstract

We reviewed the experience with infective endocarditis at some major US Army Medical Centers. One hundred patients were studied, comparing 82 patients who had native valve endocarditis (NVE) with 18 patients who had prosthetic valve endocarditis (PVE). Among patients with PVE, four had porcine valves and 14 had synthetic. None of the patients with NVE had received anticoagulants; 14 of 18 patients with PVE had received anticoagulants. The major causes of death were central nervous system hemorrhage, congestive heart failure, uncontrolled infection, and embolic phenomena. The principal cause of death in patients with PVE was CNS hemorrhage. Of the patients with PVE, 36% had symptomatic cerebral hemorrhage while receiving anticoagulants and 80% of them died.

Original languageEnglish (US)
Pages (from-to)1372-1375
Number of pages4
JournalSouthern medical journal
Volume76
Issue number11
DOIs
StatePublished - Nov 1983

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Anticoagulation in prosthetic valve endocarditis'. Together they form a unique fingerprint.

  • Cite this

    Carpenter, J. L., McAllister, C. K., Boslego, J., Brown, J., Carpenter, J. L., Chung, R., Cooper, R., Baxter Craig, D., Cross, A., Haburchak, D., Harrison, S., Hoke, C., McClain, B., Omori, D., Opal, S., Redfield, R., Sadoff, G., & Tramont, E. (1983). Anticoagulation in prosthetic valve endocarditis. Southern medical journal, 76(11), 1372-1375. https://doi.org/10.1097/00007611-198311000-00011